An Evaluation of Therapeutic Noninferiority of 0.005% Latanoprost Ophthalmic Solution and Xalatan in Patients With Glaucoma or Ocular Hypertension

201224 citationsJournal Article

Authors

This study demonstrates that 0.005% latanoprost ophthalmic solution is noninferior to Xalatan in lowering IOP and is generally well tolerated.

Good health and well-being

Published in: Journal of Glaucoma

Volume 22, Issue 9, pp. 707-712

Field-Weighted Citation Impact: 2.06